Ország: Írország
Nyelv: angol
Forrás: HPRA (Health Products Regulatory Authority)
Clindamycin
Ceva Santé Animale
QJ01FF01
Clindamycin
25 milligram(s)/millilitre
Oral solution
POM: Prescription Only Medicine as defined in relevant national legislation
Cats, Dogs
clindamycin
Antibacterial
Authorised
2016-04-22
Health Products Regulatory Authority 21 March 2019 CRN000Z32 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Zodon 25 mg/ml oral solution for cats and dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Clindamycin 25 mg (equivalent to 27.17 mg clindamycin hydrochloride) EXCIPIENTS: Ethanol 96% (E1510) 72 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral solution. Clear, amber solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats and dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cats: For the treatment of infected wounds and abscesses caused by clindamycin-susceptible species of _Staphylococcusspp_ and _Streptococcus spp_. Dogs: For the treatment of infected wounds, abscesses and oral cavity/dental infections caused by or associated with clindamycin-sensitive species of _Staphylococcus spp_, _Streptococcus spp_, _Bacteroides spp_, _Fusobacterium _ _necrophorum_, _Clostridium perfringens_ Adjunctive treatment of mechanical or surgical periodontal therapy in the treatment of infections of the gingival and periodontal tissues For the treatment of osteomyelitis caused by _Staphylococcus aureus_ 4.3 CONTRAINDICATIONS Do not use in hamsters, guinea pigs, rabbits, chinchillas, horses or ruminants because clindamycin ingestion by these species may cause severe gastrointestinal disorders. Do not use in cases of hypersensitivity to either clindamycin or lincomycin, or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Health Products Regulatory Authority 21 March 2019 CRN000Z32 Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Inappropriate use of the product may increase the prevalence of bacteria resistant to clindamycin. Whenever possible, clindamycin should only be used based on susceptibility testing includi Olvassa el a teljes dokumentumot